Dr. Lisa Mielniczuk, Cardiologist, Ottawa, ON

Dr. Lisa Mielniczuk

Dr. Lisa Mielniczuk

Cardiologist
Ottawa, ON
Bio & Education  
NEW Treatments Methods  

Dr. Lisa Mielniczuk Bio

isa Mielniczuk, MD, is an Associate Professor of Medicine at the University of Ottawa and a Cardiologist and Clinician Investigator at the University of Ottawa Heart Institute. In addition, Dr. Mielniczuk is the Director of the Heart Failure Program and Medical Director of Cardiac Transplantation Program as well as Medical Director of the Pulmonary Hypertension Clinic. Dr. Mielniczuk co-leads the Ottawa region strategic research Innovation Cluster on Heart Failure. Background  Dr. Mielniczuk graduated medical school from McMaster University in 1998 and then completed internal medicine training at Queen’s University in Kingston and a cardiology residency at the University of Ottawa Heart Institute. Following her cardiology training, Dr. Mielniczuk pursed a fellowship in heart failure and cardiac transplantation at the Brigham and Women’s Hospital and Harvard Medical School in Boston and a Masters of Science Degree in Clinical Epidemiology and Biostatistics from the Harvard School of Public Health. Dr. Mielniczuk serves on a grant peer review panel for the Heart and Stroke Foundation of Canada, and research committee for the Heart Failure Society of America. She is a committee member for the Medical Advisory Committee for Pulmonary Hypertension Association of Canada and the Canadian Thoracic Society Pulmonary Vascular Disease Steering committee. She is also an invited member of the Heart Failure Task Force for the Cardiac Care Network of Ontario, and has served as a heart failure expert for Health Quality Ontario. Dr. Mielniczuk currently holds clinical and translational science grants from the Heart and Stroke Foundation of Canada evaluating right ventricular metabolism in pulmonary hypertension. She is also co-investigator of the Canadian Institutes of Health Research IMAGE HEART FAILURE Team Grant and co-investigator on studies evaluating cardiac energetics using C-11-acetate in patients with heart failure and sleep apnea being randomized to CPAP vs. standard therapy. She has published her work in such journals as Circulation Cardiovascular Imaging, Circulation, American Journal of Cardiology and Journal of Nuclear Medicine. Research & Clinical Interests  Clinical Dr. Mielniczuk is the Director of the Heart Failure Program in Ottawa, the Medical Director of the Cardiac Transplant Program and the Medical Director of the Pulmonary Hypertension Clinic. Her clinical time is spent in the evaluation, diagnosis and management of patients with advanced heart disease, in addition to attending in the coronary care unit. Dr. Mielniczuk is leading the development of a regional heart failure program in the Ottawa area and Champlain LHIN. Research Dr. Mielniczuk is a heart failure specialist with a specific interest in evaluating metabolic adaptation in right heart failure and pulmonary hypertension (PAH). Dr. Mielniczuk’s research interests include clinical outcomes related to heart failure and pulmonary hypertension and the evaluation of myocardial energetics in right heart failure.
( Dr. Lisa Mielniczuk, Cardiologist, Ottawa, ON) is in good standing with the College of Physicians and Surgeons.

If you are looking for local services or treatment from a Local Cardiologist for reviews, contact info, practice history, affiliated hospitals & more  in the office or hospital from a Cardiologist, contact a provider such as ( Dr. Lisa Mielniczuk ) to inquire if they are accepting patients at the office you need a referral.   Phone number to book an appointment (613) 761-4059 ( Dr. Lisa Mielniczuk )  Is in good standing with the College of Physicians and Surgeons of Canada and the CANADIAN CARDIOVASCULAR SOCIETY

Keywords: Heart Health: Heart Failure, Heart Health: Atrial Fibrillation, Heart Health: Heart Attack, Heart Health: Cardiothoracic Surgery, Heart Health: Heart Disease, Heart Health: Congestive Heart Failure

The speaker in the video may have no association with ( Dr. Lisa Mielniczuk, Cardiologist Ottawa, ON ). 
( Dr. Lisa Mielniczuk, Cardiologist Ottawa, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Cardiologist at the office about the information you learnt from the videos in regards to treatments and procedures the Local Cardiologist could  perform and if they would be appropriate for you. Remember good information is the corner stone to understanding your condition or disease.

A local cardiologist can also work with your other healthcare providers, from your local registered dietitian to your local Pilates instructor.Atrial fibrillation is an irregular heartbeat, also called an arrhythmia, that can increase your risk of heart failure, stroke, blood clots and other heart conditions. A normal heart contracts and relaxes to a regular beat, but if you have atrial fibrillation, the atria (upper chambers) beat out of sync with the ventricles (lower chambers).

During a coronary angioplasty, a thin, flexible tube called a catheter is inserted into an artery, typically in the groin or wrist, and guided to the blocked or narrowed coronary artery. The catheter is equipped with a deflated balloon at its tip. Once the catheter reaches the target area, the balloon is inflated, which compresses the plaque against the artery walls and widens the artery, restoring blood flow.

In many cases, the angioplasty procedure is followed by the placement of a stent. A stent is a small, mesh-like metal tube that is inserted into the artery  of the heart after the balloon is inflated. The stent helps to keep the artery open and prevents it from re-narrowing. There are two main types of stents: bare-metal stents and drug-eluting stents. Drug-eluting stents are coated with medications that help reduce the risk of the artery re-narrowing.

Coronary angioplasty is typically performed under local anesthesia, and the patient is awake during the procedure. It is considered a minimally invasive procedure and has become a common treatment option for coronary artery disease. It can relieve symptoms such as chest pain (angina) and improve blood flow to the heart, thereby reducing the risk of heart attacks and other complications associated with CAD. The Canadain Medical Association

Please contact ( Dr. Lisa Mielniczuk, Cardiologist Ottawa, ON ) to enquire if this health care provider is accepting new patients.

Education

If you are the practitioner featured on this page and would like to either update the current information or claim the page please take advantage of our patient and physician resources here.

If on the other hand you would like to be removed for whatever reason from the directory please click here.

This content is for informational purposes only, and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare professional with any questions you may have regarding a medical condition.

QA Chat